AI-Driven Biopharma Attracts Venture Capital Growth

Johns Hopkins and Georgetown researchers analyze PitchBook VC data from 2010–2024 and find 1,679 AI-focused venture deals (5.93%) among 28,269 biopharmaceutical financings, with discovery tools showing the fastest growth—funding rose nearly 36-fold. AI-related deals became more concentrated geographically: about 50.7% were US-based in 2024 and nearly 60% of US AI deals were in California and Massachusetts, implying regional ecosystems shape investment flows.